Technical Data

G8140-01-ML650
Clone Type
Monoclonal
Host
Mouse
Source
Rabbit
Conjugate
MaxLight™650
Isotype
IgG1
Clone Number
2Q70 (6C5)
Grade
Affinity Purified
Applications
FLISA IC IF WB
Crossreactivity
Ca Fe Hu Mo Po Rb Rt
Shipping Temp
Blue Ice
Storage Temp
4°C Do Not Freeze
Notes
Preservative Free
BSA Free
Mouse Anti-Glyceraldehyde 3-Phosphate Dehydrogenase (GAPD, GAPDH) (MaxLight 650)

MaxLight™650 is a new Far-IR stable dye conjugate comparable to Alexa Fluor™647, DyLight™649, Cy5™ and offers better labeling efficiency, brighter imaging and increased immunodetection. Absorbance (655nm); Emission (676nm); Extinction Coefficient 250,000.

Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) is an ubiquitous glycolytic enzyme present in reasonably high levels in almost all tissues. As a 'house-keeping' enzyme, it catalyzes the synthesis of 1,3-biphosphoglycerate, a "high energy" intermediate used for the synthesis of ATP. Besides its cytoplasmic action in metabolism it is also involved in the initial stages of apoptosis or oxidative stress response where GAPDH is translocated to the nucleus. Such actions may reflect the role of GAPDH in DNA repair or as one nuclear carrier for apoptotic molecules. GAPDH has also been found to bind specifically to proteins implicated in the pathogenesis of a variety of neurodegenerative disorders including the beta-amyloid precursor protein and the huntingtin protein where decreased function of GAPDH is associated with Alzheimer's and Huntington's disease fibroblasts. GAPDH has also been identified as a potential target for nitric oxide (NO)-mediated cellular toxicity. The complete and functional enzyme is a tetramer with each of four identical subunits occupying the vertex of a tetrahedron. Binding domains also include one principally interacting with NAD+ and another interacting with glyceraldehyde 3-phosphate (GAP).
Applications
Suitable for use in FLISA, Western Blot, Immunocytochemistry and Immunofluorescence. Other applications have not been tested.
Recommended Dilutions
Western Blot: Detects on 10ug of A431 lysates. Immunocytochemistry: Dilute in PBS, 10mg/ml BSA. Fixative: 4% PFA, 0.02% PBS-Triton X-100. Incubation time: 3 minutes at RT. Optimal dilutions to be determined by the researcher.
Storage and Stability
Store product at 4°C in the dark. DO NOT FREEZE! Stable at 4°C for 12 months after receipt as an undiluted liquid. Dilute required amount only prior to immediate use. Further dilutions can be made in assay buffer. Caution: MaxLight™650 conjugates are sensitive to light. For maximum recovery of product, centrifuge the original vial prior to removing the cap.    
Note: Applications are based on unconjugated antibody.
Immunogen
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) from rabbit muscle.
Form
Supplied as a liquid in PBS, pH 7.2. No preservative added. Labeled with MaxLight™650.
Purity
Purified by Protein A affinity chromatography
Specificity
Recognizes glyceraldehyde-3-phosphate dehydrogenase (GAPDH) from rabbit skeletal muscle at ~38kD. Also recognizes cardiac GAPDH. Species Crossreactivity: human, porcine, canine, feline, rat, mouse and fish. Does not react with GAPDH from E. coli. Also detected in many non-muscle cell lines including HeLa, HCT-116, U937, and THP-1 cells.

Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.

References
1. Liu, S. et al., (2010) Acta Physiol (Oxf) 199; 339–346. 2. Fatima, J. et al., (2008) J. Gastrointestinal Surgery 13:634-641. 3. Iqbal, C.W. et al., (2008) J. Gastrointestinal Surgery 12: 1854-1865. 4. Qandeel, H.G. et al., (2009) J. Surgical Research 156:123-128. 5. Iqbal, C. W. et al. (2009) Surgery 146:100-112. 6. Houghton, S.G. et al., (2008) Surgery 143:79-93. 7. Houghton, S.G. et al., (2006) Surgery 139:542-549. 8. Hwang, Y.S. et al., (2006) Mol Carcinog. 45:518-5129. 9. Chui, Y.-L. et al., (2010) Biochem. Biophys. Res. Comm. 391; 1522-1525. 10. Saha, A. et al., (2012) PLoS Pathog 8(3): e1002573. doi:10.1371/journal.ppat.1002573. 11. Banerjee, S. et al., (2013) PLoS Pathogens 9(5): e1003314. doi:10.1371/journal.ppat.1003314. 1. Almeras, Linoel, et al. Proteomics. 7:769-80 (2007). 2. Kaltenbach, Linda S., et al. PLoS Genet. 3:e82 (2007). 3. Donofrio, Gaetano, et al. Microbes Infect. 8:898-904 (2006). 4. Chen, L., et al. Mole. Vision. 9:151-158 (2003). 5. Law J.W.S., Lee A.Y.W., Sun M., Nikoenko & Morellini F. J Neurosci. 23(32): 10419-10432 (2003).
USBio References
US Biological application references: 1. Liu, S. et al., (2010) Acta Physiol (Oxf) 199; 339–346. 2. Fatima, J. et al., (2008) J. Gastrointestinal Surgery 13:634-641. 3. Iqbal, C.W. et al., (2008) J. Gastrointestinal Surgery 12: 1854-1865. 4. Qandeel, H.G. et al., (2009) J. Surgical Research 156:123-128. 5. Iqbal, C. W. et al. (2009) Surgery 146:100-112. 6. Houghton, S.G. et al., (2008) Surgery 143:79-93. 7. Houghton, S.G. et al., (2006) Surgery 139:542-549. 8. Hwang, Y.S. et al., (2006) Mol Carcinog. 45:518-5129. 9. Chui, Y.-L. et al., (2010) Biochem. Biophys. Res. Comm. 391; 1522-1525. 10. Saha, A. et al., (2012) PLoS Pathog 8(3): e1002573. doi:10.1371/journal.ppat.1002573. 11. Banerjee, S. et al., (2013) PLoS Pathogens 9(5): e1003314. doi:10.1371/journal.ppat.1003314.
United States Biological | 4 Technology Way | Salem, MA 01970
Phone 800-520-3011 | Fax 978-594-8052 | Website www.usbio.net